发布求助
文献互助 智能选刊 最新文献

The Lancet Oncology最新文献

筛选
英文 中文
Correction to Lancet Oncol 2026; 27: 233–42 Lancet Oncol 2026修正；27日:233 - 42
The Lancet Oncology Pub Date : 2026-03-30 DOI: 10.1016/s1470-2045(26)00087-2
{"title":"Correction to Lancet Oncol 2026; 27: 233–42","authors":"","doi":"10.1016/s1470-2045(26)00087-2","DOIUrl":"https://doi.org/10.1016/s1470-2045(26)00087-2","url":null,"abstract":"","PeriodicalId":22865,"journal":{"name":"The Lancet Oncology","volume":"239 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147587108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spaceflight as a cancer research catalyst 航天作为癌症研究的催化剂
The Lancet Oncology Pub Date : 2026-03-30 DOI: 10.1016/s1470-2045(26)00135-x
Jessica Pham, Inge van der Werf, Karla Mack, Catriona Jamieson
{"title":"Spaceflight as a cancer research catalyst","authors":"Jessica Pham, Inge van der Werf, Karla Mack, Catriona Jamieson","doi":"10.1016/s1470-2045(26)00135-x","DOIUrl":"https://doi.org/10.1016/s1470-2045(26)00135-x","url":null,"abstract":"","PeriodicalId":22865,"journal":{"name":"The Lancet Oncology","volume":"421 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147587101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implications of indiscriminate testing for cancer susceptibility genes 不加区分地检测癌症易感基因的意义
The Lancet Oncology Pub Date : 2026-03-30 DOI: 10.1016/s1470-2045(26)00081-1
Alice Garrett
{"title":"Implications of indiscriminate testing for cancer susceptibility genes","authors":"Alice Garrett","doi":"10.1016/s1470-2045(26)00081-1","DOIUrl":"https://doi.org/10.1016/s1470-2045(26)00081-1","url":null,"abstract":"","PeriodicalId":22865,"journal":{"name":"The Lancet Oncology","volume":"31 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147587110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ALND after neoadjuvant chemotherapy: a call for caution 新辅助化疗后ALND：需谨慎
The Lancet Oncology Pub Date : 2026-03-30 DOI: 10.1016/s1470-2045(26)00022-7
Kefah Mokbel, Umar Wazir
{"title":"ALND after neoadjuvant chemotherapy: a call for caution","authors":"Kefah Mokbel, Umar Wazir","doi":"10.1016/s1470-2045(26)00022-7","DOIUrl":"https://doi.org/10.1016/s1470-2045(26)00022-7","url":null,"abstract":"","PeriodicalId":22865,"journal":{"name":"The Lancet Oncology","volume":"61 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147587113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancing cancer equity in seven high-income countries: an analysis of policy levers and National Cancer Control Plans 促进七个高收入国家的癌症公平：政策杠杆和国家癌症控制计划分析
The Lancet Oncology Pub Date : 2026-03-30 DOI: 10.1016/s1470-2045(26)00072-0
Rebecca Zosel MPH, Ambreen Sayani PhD, Daniel Chaji MSc, Merilyn Penn BA, David Meredyth, Prof Adam G Elshaug PhD, G7 Cancer Working Group 3 (Cancer Outcome Inequities), Dr Jérôme Foucaud HDR, Ms Anne-Fleur Guillemin MSc, Dr Connie Hoe PhD, Dr Jake Howden PhD, Dr Lina Jansen PhD, Dr Kota Katanoda PhD, Dr Jacqueline JT Marshall PhD, Mr David Meredyth N/A, Dr Ambreen Sayani PhD, Ms Julia Schippke MA, Dr Salvatore Vaccarella PhD, Prof Karen Winkfield MD
{"title":"Advancing cancer equity in seven high-income countries: an analysis of policy levers and National Cancer Control Plans","authors":"Rebecca Zosel MPH, Ambreen Sayani PhD, Daniel Chaji MSc, Merilyn Penn BA, David Meredyth, Prof Adam G Elshaug PhD, G7 Cancer Working Group 3 (Cancer Outcome Inequities), Dr Jérôme Foucaud HDR, Ms Anne-Fleur Guillemin MSc, Dr Connie Hoe PhD, Dr Jake Howden PhD, Dr Lina Jansen PhD, Dr Kota Katanoda PhD, Dr Jacqueline JT Marshall PhD, Mr David Meredyth N/A, Dr Ambreen Sayani PhD, Ms Julia Schippke MA, Dr Salvatore Vaccarella PhD, Prof Karen Winkfield MD","doi":"10.1016/s1470-2045(26)00072-0","DOIUrl":"https://doi.org/10.1016/s1470-2045(26)00072-0","url":null,"abstract":"Persistent inequities in cancer outcomes remain a defining challenge for global health systems, including in high-income countries. Despite advances across prevention, early detection, treatment, and survivorship, disparities persist, reflecting entrenched social and structural inequities. While equity is increasingly articulated within national and global cancer agendas, comparative analysis of how equity is conceptualised and operationalised in national cancer control planning remains limited. This Policy Review addresses this gap by synthesising evidence across seven high-income countries comprising the G7 Cancer collaboration—Australia, Canada, France, Germany, Japan, the UK, and the USA—drawing on policy frameworks, National Cancer Control Plans (NCCPs), and semi-structured expert interviews. The Policy Review identifies marked variation in equity definitions and application, with most countries emphasising access to care, fewer addressing outcomes or patient experience, and equity often being framed as secondary to broader health system goals. Terminology is inconsistently applied and action on structural determinants is limited. Barriers to NCCP implementation encompass fragmented accountability, restricted policy mandates, and fiscal or cultural sensitivities. Enablers of effective NCCP implementation include data infrastructure systems, multistakeholder engagement, legislative frameworks, and cross-sector collaboration. Synthesising these findings, we present an evidence-informed Policy Framework for Equity in Cancer Control, to guide equitable cancer policy in high-income settings.","PeriodicalId":22865,"journal":{"name":"The Lancet Oncology","volume":"61 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147587117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
KRASG12C inhibitor combination therapy in metastatic non-small-cell lung cancer: choosing the right path KRASG12C抑制剂联合治疗转移性非小细胞肺癌：选择正确的途径
The Lancet Oncology Pub Date : 2026-03-30 DOI: 10.1016/s1470-2045(26)00119-1
Tämer El Saadany, Adrian Sacher
{"title":"KRASG12C inhibitor combination therapy in metastatic non-small-cell lung cancer: choosing the right path","authors":"Tämer El Saadany, Adrian Sacher","doi":"10.1016/s1470-2045(26)00119-1","DOIUrl":"https://doi.org/10.1016/s1470-2045(26)00119-1","url":null,"abstract":"","PeriodicalId":22865,"journal":{"name":"The Lancet Oncology","volume":"61 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147587105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From reliability to implementable toxicity policy in PRO-informed CTCAE – Authors' reply 从可靠性到PRO-informed CTCAE中可执行的毒性政策——作者的回复
The Lancet Oncology Pub Date : 2026-03-30 DOI: 10.1016/s1470-2045(26)00118-x
Lisa M Wintner, Johannes M Giesinger
{"title":"From reliability to implementable toxicity policy in PRO-informed CTCAE – Authors' reply","authors":"Lisa M Wintner, Johannes M Giesinger","doi":"10.1016/s1470-2045(26)00118-x","DOIUrl":"https://doi.org/10.1016/s1470-2045(26)00118-x","url":null,"abstract":"","PeriodicalId":22865,"journal":{"name":"The Lancet Oncology","volume":"21 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147587106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
US cancer vaccines research at “tipping point” as NCI backs $200 million initiative 美国癌症疫苗研究处于“转折点”，NCI支持2亿美元的倡议
The Lancet Oncology Pub Date : 2026-03-27 DOI: 10.1016/s1470-2045(26)00167-1
Bryant Furlow
{"title":"US cancer vaccines research at “tipping point” as NCI backs $200 million initiative","authors":"Bryant Furlow","doi":"10.1016/s1470-2045(26)00167-1","DOIUrl":"https://doi.org/10.1016/s1470-2045(26)00167-1","url":null,"abstract":"No Abstract","PeriodicalId":22865,"journal":{"name":"The Lancet Oncology","volume":"24 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147524702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Carcinogenicity of tris(chloropropyl) phosphate, butyraldehyde, and cumyl hydroperoxide 磷酸三（氯丙基）、丁醛和过氧化三酰的致癌性
The Lancet Oncology Pub Date : 2026-03-27 DOI: 10.1016/s1470-2045(26)00168-3
Dirk W Lachenmeier, Victoria H Arrandale, David M DeMarini, Tatiana Ruksha, Mohamed A-E Abdallah, Giuliano Bettini, Yuji Ishii, Carina Ladeira, Jingbo Pi, Pavel Rossner, Kristen R Ryan, Barbara Stefanska, Maaike van Gerwen, Marta Venier, Aline de Conti, Caterina Facchin, Andrew T Kunzmann, Federica Madia, Elisa Pasqual, Roland Wedekind, Mary K Schubauer-Berigan
{"title":"Carcinogenicity of tris(chloropropyl) phosphate, butyraldehyde, and cumyl hydroperoxide","authors":"Dirk W Lachenmeier, Victoria H Arrandale, David M DeMarini, Tatiana Ruksha, Mohamed A-E Abdallah, Giuliano Bettini, Yuji Ishii, Carina Ladeira, Jingbo Pi, Pavel Rossner, Kristen R Ryan, Barbara Stefanska, Maaike van Gerwen, Marta Venier, Aline de Conti, Caterina Facchin, Andrew T Kunzmann, Federica Madia, Elisa Pasqual, Roland Wedekind, Mary K Schubauer-Berigan","doi":"10.1016/s1470-2045(26)00168-3","DOIUrl":"https://doi.org/10.1016/s1470-2045(26)00168-3","url":null,"abstract":"No Abstract","PeriodicalId":22865,"journal":{"name":"The Lancet Oncology","volume":"49 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147524251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
US oil blockade pushes Cuba's health system into crisis 美国的石油封锁使古巴的卫生系统陷入危机
The Lancet Oncology Pub Date : 2026-03-27 DOI: 10.1016/s1470-2045(26)00166-x
Sharmila Devi
{"title":"US oil blockade pushes Cuba's health system into crisis","authors":"Sharmila Devi","doi":"10.1016/s1470-2045(26)00166-x","DOIUrl":"https://doi.org/10.1016/s1470-2045(26)00166-x","url":null,"abstract":"No Abstract","PeriodicalId":22865,"journal":{"name":"The Lancet Oncology","volume":"17 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2026-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147535945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信
小红书